Urine.jpgQuestion: Why is urine testing the most frequently used method for drug testing?

Businesses that drug test their applicants and employees do so to minimize their exposure to the risks of employee drug use. While all drug test specimen types – urine, oral fluid and hair – have their advantages, urine drug testing is by far the most flexible and customizable. With hundreds of different combinations of detectable drugs, test codes and cutoff levels, there’s a urine testing panel for almost any reason for testing. Other advantages of urine drug testing include:

  • The ability to detect recent drug use
  • Fast, consistent result turnaround times from the laboratory
  • It’s a proven methodology – with millions of tests performed each year
  • Drug test collections are performed  at almost every collection site
  • It is the only specimen type approved for Department of Transportation (DOT) testing, which has helped to evangelize its status as the tried and true ‘gold standard’ of workplace drug testing.

For more information about lab-based urine drug testing and how to build an effective program, contact us online.

National Drug Early Warning System

by Landon Todd on August 26, 2014

SpiceSynthetic drug use presents unique challenges for employers to navigate. As a relatively new phenomenon, the existence of these drugs is neither widely known nor understood. Hundreds of different compounds are used to create these designer drugs, and with so many different combinations available, it can be challenging to identify them.

The Center for Substance Abuse Research (CESAR) has partnered with the National Institute on Drug Abuse (NIDA) to develop the National Drug Early Warning System (NDEWS). This system will monitor emerging drug trends that will help health experts identify increasing use of designer synthetic compounds. The system will scan conventional data resources, like the Quest Diagnostics Drug Testing Index™, along with social media outlets and other web platforms to identify new drug trends.

“NDEWS will generate critically needed information about new drug trends in specific locations around the country so rapid, informed, and effective public health responses can be developed precisely where needed,” said NIDA Director Dr. Nora D. Volkow. “By monitoring trends at the local level, we hope to prevent emerging drug problems from escalating or spreading to surrounding regions.”

CESAR FAX provides a monthly, one-page overview of timely substance abuse trends or issues. Read the latest issue for more information.

Name that Drug – Pain Game: The Substitute Player

August 20, 2014 Quest News

DATIA focus is the quarterly publication of the Drug & Alcohol Testing Industry Association (DATIA). DATIA focus features a regular, popular column titled, “Name that Drug” where interesting facts about a mystery drug are described in advance of the name being revealed. The latest edition of “Name that Drug” was written by Dr. Vinnette Batiste […]

Read the full article →

Continuous Lab Improvements

August 4, 2014 Quest News

As a leader in the drug testing industry, we diligently focus on our laboratories and our testing processes. We train our teams to be efficient in their roles as tests move swiftly throughout our labs. We track the status of every specimen from the moment it arrives into one of our SAMHSA-certified laboratories. We ensure […]

Read the full article →

Prescription Opioids: A Dose of Reality

July 29, 2014 Drugs Tested

For people with chronic and reoccurring pain, opioids, such as Hydrocodone and Oxycodone, not only relieve suffering, but can help support a normal lifestyle, alleviate stress and improve sleep. But there is a downside – prescription opioids can be just as addictive and dangerous as illegal drugs. Prescription drug abuse is the nation’s fastest-growing drug […]

Read the full article →

New Quest Study Examines Prescription Drug Misuse

July 21, 2014 Quest News

Quest Diagnostics released a Health Trends™ report with a three-year analysis of prescription drug use from more than 1.4 million test results. The study examined the risks of prescription drug misuse and efforts at the state level to reduce abuse. Patients, regardless of age or gender, sometimes use dangerous drug combinations and skip doses. Michael […]

Read the full article →

Ask the Experts: Reasonable Suspicion Drug Testing

July 17, 2014 Ask the Experts

Question: If I suspect my employee is under the influence of drugs or alcohol at work, what can I do? Employers who implement pre-employment drug testing programs do so to protect their businesses from the impact of drug abuse before making hiring decisions. As a result, they help to strengthen the integrity of their workplace […]

Read the full article →

Drug Testing Collection Site Network

July 15, 2014 Collection Services

Our drug testing collection site network consists of more than 8,000 locations across the country, and helps to ensure a convenient, consistent, high-quality experience for the donors of our employer customers. But not all collection sites are created equal, and it’s important to know the differences between each type of site when making a location […]

Read the full article →

Revised Urine Specimen Collector Guidelines

July 3, 2014 Collection Services

Earlier this month, the Office of Drug and Alcohol Policy and Compliance (ODAPC) issued an official Question & Answer document that clarifies collector guidelines outlined in 49 CFR Part 40. Specifically, the document addresses when a collector can give a donor permission to leave the collection site, and what a collector should do if a […]

Read the full article →

Ask the Experts: Hair Testing vs. Hair Follicle Testing

July 3, 2014 Ask the Experts

Question: What is the difference between hair testing and hair follicle testing? Calling a hair test a hair follicle test is a common misnomer. We looked to Jarod Rowland, a scientific expert in our Lenexa, Kansas hair testing laboratory, to better understand hair testing terminology and the hair testing collection process. The hair follicle is […]

Read the full article →